European contribution to the science, prevention and management of HIV infection

T. Lehner; P. Biberfeld; C. Boucher; J. Darbyshire; E. M. Fenyo; J. L. Heeney; J. C. Jager; J. D. Lundgren; M. L. Newell; P. Rosch; P. Rossi; J. L. Virelizier

doi:10.1016/S0264-410X(97)00014-5

European contribution to the science, prevention and management of HIV infection

T. Lehner, P. Biberfeld, C. Boucher, J. Darbyshire, E. M. Fenyo, J. L. Heeney, J. C. Jager, J. D. Lundgren, M. L. Newell, P. Rosch, P. Rossi, J. L. Virelizier

Ospedale Pediatrico Bambino Gesu

Research output: Contribution to journal › Article › peer-review

Abstract

The objectives of the European Commission Biomed AIDS Programme are to enable Europe to pool its intellectual and financial resources in the control, treatment and prevention of HIV infection and AIDS. In order to facilitate this aim the Commission has allocated 40 to 50 million ECU over the past 6 years for concerted action of the Biomed projects on AIDS by the countries of the European Union. This is only a small proportion of the real cost spent by the member countries on this epidemic.

Original language	English
Pages (from-to)	465-468
Number of pages	4
Journal	Vaccine
Volume	15
Issue number	5
DOIs	https://doi.org/10.1016/S0264-410X(97)00014-5
Publication status	Published - 1997

Keywords

AIDS
European commission
HIV

ASJC Scopus subject areas

Immunology
Microbiology
Virology
Infectious Diseases
Public Health, Environmental and Occupational Health
veterinary(all)

Access to Document

10.1016/S0264-410X(97)00014-5

Cite this

@article{f9b0775790f64d2ab03e728510c552b0,

title = "European contribution to the science, prevention and management of HIV infection",

abstract = "The objectives of the European Commission Biomed AIDS Programme are to enable Europe to pool its intellectual and financial resources in the control, treatment and prevention of HIV infection and AIDS. In order to facilitate this aim the Commission has allocated 40 to 50 million ECU over the past 6 years for concerted action of the Biomed projects on AIDS by the countries of the European Union. This is only a small proportion of the real cost spent by the member countries on this epidemic.",

keywords = "AIDS, European commission, HIV",

author = "T. Lehner and P. Biberfeld and C. Boucher and J. Darbyshire and Fenyo, {E. M.} and Heeney, {J. L.} and Jager, {J. C.} and Lundgren, {J. D.} and Newell, {M. L.} and P. Rosch and P. Rossi and Virelizier, {J. L.}",

year = "1997",

doi = "10.1016/S0264-410X(97)00014-5",

language = "English",

volume = "15",

pages = "465--468",

journal = "Vaccine",

issn = "0264-410X",

publisher = "Elsevier BV",

number = "5",

}

TY - JOUR

T1 - European contribution to the science, prevention and management of HIV infection

AU - Lehner, T.

AU - Biberfeld, P.

AU - Boucher, C.

AU - Darbyshire, J.

AU - Fenyo, E. M.

AU - Heeney, J. L.

AU - Jager, J. C.

AU - Lundgren, J. D.

AU - Newell, M. L.

AU - Rosch, P.

AU - Rossi, P.

AU - Virelizier, J. L.

PY - 1997

Y1 - 1997

N2 - The objectives of the European Commission Biomed AIDS Programme are to enable Europe to pool its intellectual and financial resources in the control, treatment and prevention of HIV infection and AIDS. In order to facilitate this aim the Commission has allocated 40 to 50 million ECU over the past 6 years for concerted action of the Biomed projects on AIDS by the countries of the European Union. This is only a small proportion of the real cost spent by the member countries on this epidemic.

AB - The objectives of the European Commission Biomed AIDS Programme are to enable Europe to pool its intellectual and financial resources in the control, treatment and prevention of HIV infection and AIDS. In order to facilitate this aim the Commission has allocated 40 to 50 million ECU over the past 6 years for concerted action of the Biomed projects on AIDS by the countries of the European Union. This is only a small proportion of the real cost spent by the member countries on this epidemic.

KW - AIDS

KW - European commission

KW - HIV

UR - http://www.scopus.com/inward/record.url?scp=0030903172&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030903172&partnerID=8YFLogxK

U2 - 10.1016/S0264-410X(97)00014-5

DO - 10.1016/S0264-410X(97)00014-5

M3 - Article

C2 - 9160511

AN - SCOPUS:0030903172

VL - 15

SP - 465

EP - 468

JO - Vaccine

JF - Vaccine

SN - 0264-410X

IS - 5

ER -

European contribution to the science, prevention and management of HIV infection

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this